Who are chlorhexidine 0.12%/Ethyl alcohol 7%'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Iodophor 0.7% and IPA 74% w/w, Povidone-iodine irrigation, Povidone Iodine Topical, Lugols Strong Iodine, Povidone-Iodine 0.3%, Sodium Hypochlorite Solution.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/chlorhexidine-0-12-ethyl-alcohol-7.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

chlorhexidine 0.12%/Ethyl alcohol 7% — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

chlorhexidine 0.12%/Ethyl alcohol 7% (chlorhexidine 0.12%/Ethyl alcohol 7%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: disinfectant. Area: Infectious Disease.

phase 3 disinfectant Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

chlorhexidine 0.12%/Ethyl alcohol 7% (chlorhexidine 0.12%/Ethyl alcohol 7%) — Hospital Regional de Alta Especialidad del Bajio. Chlorhexidine acts as a disinfectant by disrupting bacterial cell membranes, ultimately leading to cell death.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
chlorhexidine 0.12%/Ethyl alcohol 7% TARGET	chlorhexidine 0.12%/Ethyl alcohol 7%	Hospital Regional de Alta Especialidad del Bajio	phase 3	disinfectant
Iodophor 0.7% and IPA 74% w/w	Iodophor 0.7% and IPA 74% w/w	Johns Hopkins University	marketed	Topical antiseptic/disinfectant
Povidone-iodine irrigation	Povidone-iodine irrigation	Corewell Health East	marketed	Topical antiseptic/disinfectant
Povidone Iodine Topical	Povidone Iodine Topical	Mary K Hayden	marketed	Topical antiseptic/disinfectant	Microbial cell membranes and proteins (non-selective)
Lugols Strong Iodine	Lugols Strong Iodine	Jesús María Villar del Moral	marketed	Topical antiseptic/disinfectant	Microbial proteins and nucleic acids (non-specific oxidative mechanism)
Povidone-Iodine 0.3%	Povidone-Iodine 0.3%	Norwegian University of Science and Technology	marketed	Topical antiseptic/disinfectant
Sodium Hypochlorite Solution	Sodium Hypochlorite Solution	University of Sulaimani	marketed	Disinfectant/Antiseptic

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (disinfectant class)

Hospital Regional de Alta Especialidad del Bajio · 1 drug in this class
loren g miller · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). chlorhexidine 0.12%/Ethyl alcohol 7% — Competitive Intelligence Brief. https://druglandscape.com/ci/chlorhexidine-0-12-ethyl-alcohol-7. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab